Shumway, Alexandria J.Shanahan, Michael T.Hollville, EmilieChen, KevinBeasley, CarolineVillanueva, Jonathan W.Albert, SaraLian, GraceCure, Moises R.Schaner, MatthewZhu, Lee ChingBantumilli, SurekhaDeshmukh, MohanishFurey, Terrence S.Sheikh, Shehzad Z.Sethupathy, Praveen2024-04-012024-04-012024-02-22Shumway, A J, Shanahan, M T, Hollville, E, Chen, K, Beasley, C, Villanueva, J W, Albert, S, Lian, G, Cure, M R, Schaner, M, Zhu, L C, Bantumilli, S, Deshmukh, M, Furey, T S, Sheikh, S Z & Sethupathy, P 2024, 'Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn’s disease', JCI Insight, vol. 9, no. 4, e168800. https://doi.org/10.1172/jci.insight.1688002379-3708unpaywall: 10.1172/jci.insight.168800ORCID: /0000-0001-5711-8542/work/156708947https://hdl.handle.net/2164/23145Funding Information: This work was supported by 5P01DK094779 (NIH/NIDDK) awarded to SZS, TSF, and PS; the NIDDK R01 DK136262 awarded to SZS; and 5R21HD104922-02 (NIH/NICHD) awarded to PS. We would also like to thank BioRender for its help in creating our graphical abstract.194000963engAdultAnimalsMiceHumansChildCrohn Disease/pathologyMicroRNAs/geneticsPhenotypeInflammationR Medicine (General)General MedicineR1Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn’s diseaseJournal article10.1172/jci.insight.168800http://www.scopus.com/inward/record.url?scp=85185619325&partnerID=8YFLogxK94